Comparative Study of Clinical Outcome in Kidney Transplantation Between Early Steroid Withdrawal Protocol Using Basiliximab, Calcineurin Inhibitor, and Mycophenolate Mofetil and Triple Regimen Consisting of Calcineurin Inhibitor, Mycophenolate Mofetil, an

Early steroid withdrawal protocol using basiliximab is promising for reducing the incidence of AR (especially steroid-resistant rejection), CMV diseases, and steroid-related complications.